Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as the number of tests increases year-over-year. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists reduce diagnostic error-rate, obtain 100% quality control and enable a more efficient workflow. Deployed worldwide, our Galen Breast and the CE-marked Galen Prostate are the first-ever AI-powered cancer diagnostics solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: Transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year.
Total Funding: $13.6 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2016
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Ibex Medical Analytics
Senior Researcher / Data Scientist
Tel Aviv, Tel Aviv
Algorithm Engineer
Tel Aviv, Tel Aviv
Outstanding Software Engineer
Tel Aviv, Tel Aviv
Production Engineer
Tel Aviv, Tel Aviv
Web Architect
Tel Aviv, Tel Aviv
Ibex Medical Analytics - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Ibex Medical Analytics - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started